Advertisement
David Willman

David Willman is a reporter for the Los Angeles Times based in Washington, D.C. He won the Pulitzer Prize for investigative reporting in 2001 for work that prompted the market withdrawal of Rezulin, a widely sold diabetes drug. His subsequent reports on pharmaceutical industry payments to federal researchers triggered a ban of such compensation at the National Institutes of Health. His other national honors include Sigma Delta Chi’s top award in 2009 for Washington-based reporting.
Trump administration moves to boost homeland missile defense system despite multiple flaws

Citing North Korea’s growing nuclear threat, the Trump administration is moving to swiftly expand the country's problem-...

Flynn guilty plea brings Mueller investigation directly into the White House

Michael Flynn, President Trump's former national security advisor, reached a plea deal with special counsel Robert S. Mu...

Advertisement
Advertisement